You may know of Ro hair loss as “Roman,” the initial name of the digital and goal-oriented healthcare brand. What started as a one-stop shop for at-home erectile dysfunction (ED) meds like generic ...

Ro, formerly known as Roman, offers telehealth services for hair loss, erectile dysfunction, fertility, and weight loss. The company provides discreet packaging and fast shipping. Ro Body is the brand ...

Ro’s co-founder and chief growth officer Rob Schutz is stepping back from his current role and will stay involved with the digital health company in an advisory role, TechCrunch has learned. The shift ...

Ro — formerly called Roman — is a telehealth company offering services for individuals with a number of common health concerns, including erectile dysfunction (ED), fertility, hair loss, weight loss, ...

Ro Sparks is an innovative erectile dysfunction (ED) treatment developed by Ro, a company originally known as Roman. This medication is designed to provide a convenient and effective solution for men ...

The startup Ro just started prescribing "compounded" semaglutide, an alternative to Ozempic. It's the first big company to do so, despite warnings that the knockoff weight-loss shots could be risky.

Ro's Body Program is a comprehensive weight loss solution that offers personalized plans utilizing a glucagon-like peptide-1 (GLP-1) receptor agonist medications such as Ozempic, Wegovy and Zepbound.

Maintaining a healthy weight is one of the most crucial aspects of improving your overall wellness. From heart health to joint pain and everything in between, your weight has a far-reaching impact.

Potential side effects: Headache, dizziness, stuffy nose, flushing, back pain, and muscle pain Who qualifies: Adults who are ...

A week after healthcare unicorn Ro landed capital from existing investors at a higher valuation, two top executives have parted ways with the company, per an internal email obtained by TechCrunch from ...

Thank you for submitting your question. Keep reading Forbes Advisor for the chance to see the answer to your question in one of our upcoming stories. Our editors also may be in touch with follow-up ...